HEARTio develops ECGio, an AI software that analyzes electrocardiograms to detect plaque build-up in coronary arteries, enabling faster and more accurate identification of cardiovascular disease. This technology reduces the need for extensive testing, providing timely diagnoses at a lower cost for both clinicians and patients.
Funding
$870K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current methods for detecting coronary artery disease often involve a series of tests to rule out potential diagnoses, which can be time-consuming and costly for both clinicians and patients. There is a need for faster and more accurate tools to identify cardiovascular issues early in the triage process.
Solution
HEARTio's ECGio is an AI-powered software designed to analyze electrocardiograms (ECGs) and detect plaque buildup in a patient's coronary arteries. ECGio leverages deep learning to provide clinicians with a stronger diagnostic tool that can be used quickly and without specialized training or workflow adjustments. The software aims to expedite the diagnostic process, reduce the need for extensive downstream testing, and provide peace of mind for patients by delivering accurate diagnoses more rapidly.
Target Audience
The primary target audience includes clinicians and healthcare providers involved in cardiac triage, as well as hospitals and clinics seeking to improve the speed and accuracy of cardiovascular disease detection.
Features
- AI-powered analysis of standard 12-lead ECGs for plaque detection
- Deep learning algorithms that rival the diagnostic power of downstream testing
- Rapid results in seconds, without specialized training
- Integration into existing clinical workflows
- Identification of the presence, location, and severity of coronary artery disease